Position in INSM
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$266,550
New position
Shares Held
2,500
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#456
of 663 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026GABELLI & Co INVESTMENT ADVISERS, INC. holds $24,827,558 across 10 Biotechnology names. INSM ranks #6 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
161,250 | $11,392,312 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
81,645 | $10,836,740 | |
| 3 | CYTK |
Cytokinetics Inc
|
10,528 | $896,880 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,450 | $833,396 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,500 | $335,160 | |
| 6 | INSM |
INSMED Inc
This page
|
2,500 | $266,550 | |
| 7 | ABVX |
Abivax S.A.
|
2,000 | $266,520 | |
| 8 | 159,003 | $0 |
All Filings in INSM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $266,550 | 2,500 | Shares | Sole | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||